TrumpRx is Reshaping Access. Valeris is Pharma's Strategic Partner.

The 2025 negotiations with pharmaceutical giants by the Trump administration included Direct-to-Patient (DTP) products – products for which pricing is intended to be transparent and significantly lower than the list price. Patients may access therapy directly through brand websites (including telehealth), thus reducing the PBM’s active management of the plan formulary. This recent shift to increase patient choice and reduce price may be a leading indicator of a broadening trend in the industry, now facilitated at the government level through TrumpRx.

Via the TrumpRx website, manufacturers may connect consumers and patients to direct-to-patient pricing. Consumers, patients, and prescribers across the US can check for their medications of interest on the site, enroll in a specific program, and have therapy delivered to their doorstep.

For products that Valeris partners make available through TrumpRx, our team delivers a strategic partnership and patient-centric support via:

• Activation: We partner through education and enrollment, ensuring patients are informed and eligibility for DTP pricing is both timely and accurate.
• Product Dispensing: We facilitate dispensing through our nationwide network of pharmacies or triage the prescription to a pharmacy of the patient’s choice.
• Ready Access: Our Patient Pay capabilities ensure patient access across the manufacturer’s preferred pharmacy network.
• Adherence: We engage with patients after product is dispensed, addressing follow-up inquiries regarding access and facilitating refills.

Our Pharmacy and Patient Access teams are committed to ensuring patients across the U.S. receive the medications they need when they need them. Through connected workflows and impactful automation, our teams serve high volumes of patients without disrupting care or delaying time to therapy. In this new era of access, Valeris sits at the forefront of ensuring every patient receives the therapy they need, at the right price, delivered at the right time.

For manufacturers navigating the changing landscape of direct-to-patient access, Valeris is poised to meet the challenge with you. We invite you to reach out to your Valeris contact directly or connect with us at https://www.valeris.com/get-started/

About Valeris:
Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris products commercialization solutions to more than 500 life sciences partners and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com.